Lyell Immunopharma (LYEL) Revenue (2020 - 2026)
Lyell Immunopharma recorded quarterly Revenue of $2000.0 in Q1 2026, down 66.67% quarter-over-quarter from $6000.0 in Q4 2025, and down 71.43% year-over-year from $7000.0 in Q1 2025.
Lyell Immunopharma's Revenue history runs 7 years deep, the most recent figure standing at $2000.0 for Q1 2026.
- In Q1 2026, Revenue fell 71.43% year-over-year to $2000.0; the TTM figure through Mar 2026 stood at $31000.0 (down 52.31% YoY), while the FY2025 annual figure was $36000.0, down 40.98% from the prior year.
- Revenue came in at $2000.0 for Q1 2026 at Lyell Immunopharma, down from $6000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $48.4 million in Q4 2022 to a low of $2000.0 in Q1 2026.
- A 5-year average of $5.0 million and a median of $13000.0 in 2023 frame the typical range for Revenue.
- Across the five-year window, Revenue surged 1614.6% in 2022 and slumped 99.97% in 2023, its largest moves.
- Lyell Immunopharma's Revenue stood at $48.4 million in 2022, then plunged by 99.97% to $13000.0 in 2023, then retreated by 15.38% to $11000.0 in 2024, then plunged by 45.45% to $6000.0 in 2025, then sank by 66.67% to $2000.0 in 2026.
- According to Business Quant data, Revenue over the past three periods registered $2000.0, $6000.0, and $15000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Lyell Immunopharma | 379.11 Mn | 379.11 Mn | - | 2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | 15,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Jun 30, 2024 | 13,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 13,000.00 |
| Sep 30, 2023 | 25,000.00 |
| Jun 30, 2023 | 27,000.00 |
| Mar 31, 2023 | 65,000.00 |
| Dec 31, 2022 | 48.39 Mn |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 35.74 Mn |
| Mar 31, 2022 | 553,000.00 |
| Dec 31, 2021 | 2.82 Mn |
| Sep 30, 2021 | 2.76 Mn |
| Jun 30, 2021 | 2.63 Mn |
| Mar 31, 2021 | 2.45 Mn |
| Dec 31, 2020 | 2.31 Mn |
| Sep 30, 2020 | 1.07 Mn |
| Jun 30, 2020 | 3.12 Mn |